Efficacy of chlorhexidine-thymol varnish (Cervitec) against plaque accumulation and gingival inflammation in a geriatric population.

OBJECTIVES

To determine whether the 3-monthly application of chlorhexidine (CHX)-thymol varnish is an effective method of controlling plaque and gingivitis in a group of institutionalised elderly as a complement to their usual oral hygiene practices.

DESIGN

A 6-month double-blind clinical trial.

SETTING

Two residential homes in Almería (Spain).

PARTICIPANTS

Fifty-six dentate subjects aged above 64 years who completed the 6-month study.

INTERVENTION: The study subjects were randomly assigned to one of two groups (Cervitec or placebo). Varnishes were applied twice in the first week of the study and were applied again a month later and every 3 months until the end of the study. The patients continued with their usual oral hygiene practices throughout the study.

MEASUREMENT: Plaque index and gingival index scores were determined at baseline and after 1, 3 and 6 months.

RESULTS

Treatment with Cervitec varnish had a statistically significant effect overtime on the gingival index score (p = 0.029), but not on the plaque index score (p = 0.651). The groups did not significantly differ in reductions in plaque or gingival index scores between baseline and 1, 3 or 6 months.

CONCLUSION

According to these results, Cervitec, a CHX-thymol varnish, does not appear to reduce plaque and gingivitis by a 3-monthly application in the institutionalised elderly with poor oral hygiene. Wider studies are required to investigate different varnishing protocols in geriatric populations.